Hydrogen peroxide (H202) is a reactive oxygen species (ROS), which possesses the relative stability, neutrality, and small size required for a freely diffusible signaling molecule. ROS are generated in vascular cells by the mitochondria and by the enzyme NADPH oxidase, and have been shown to play an important role in a wide variety of human diseases, especially vascular diseases. Low concentrations of H202 (<10 microM) are mitogenic when applied to human cells in culture, and these low concentrations stimulate endothelial migration and tube-formation in an in vitro model of angiogenesis. In contrast, higher concentrations (50 microM to 1mM) of H202 cause growth arrest, apoptosis, and/or necrosis. Although several signal transduction pathways have been reported to be activated by the application of these higher concentrations of H202, the molecular mechanisms by which low concentrations (< 10 microM) of H202 function in mammalian cells are poorly understood. Recently, using a functional proteomics approach it has been determined that low concentrations of H202 stimulate the transient phosphorylation of heterogeneous nuclear ribonucleoprotein (hnRNP) C1/C2, and also stimulate the post-translational modification of pyruvate kinase M2 with alteration of its enzymatic activity. The overall goal of this proposal is to identify signaling pathways for sensing low physiologically relevant concentrations of H202 in human endothelial cells. To this end, the biochemical response of human endothelial cells to low concentrations of H202 will be explored in three focused specific aims: (1) Determine how low concentrations of H202 stimulate the transient phosphorylation of hnRNP C1/C2 in human endothelial cells and elucidate the functional consequences of this modification. (2) Identify the H202-stimulated post-translational modification on pyruvate kinase, determine the mechanism by which this modification occurs, and further characterize its functional consequences. (3) Identify and characterize additional protein modifications stimulated by low concentrations of H202, and use this information to establish signaling pathways for sensing H202 in human endothelial cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
7R01HL074324-02
Application #
6819912
Study Section
Pathology A Study Section (PTHA)
Project Start
2003-07-01
Project End
2007-06-30
Budget Start
2003-10-01
Budget End
2004-06-30
Support Year
2
Fiscal Year
2003
Total Cost
$248,332
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Panchenko, Mikhail P; Silva, Nilsa; Stone, James R (2009) Up-regulation of a hydrogen peroxide-responsive pre-mRNA binding protein in atherosclerosis and intimal hyperplasia. Cardiovasc Pathol 18:167-72
Cizek, Stephanie M; Bedri, Shahinaz; Talusan, Paul et al. (2007) Risk factors for atherosclerosis and the development of preatherosclerotic intimal hyperplasia. Cardiovasc Pathol 16:344-50
Bedri, Shahinaz; Cizek, Stephanie M; Rastarhuyeva, Iryna et al. (2007) Regulation of protein kinase CK1alphaLS by dephosphorylation in response to hydrogen peroxide. Arch Biochem Biophys 466:242-9
Stone, James R; Yang, Suping (2006) Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8:243-70
Talusan, Paul; Bedri, Shahinaz; Yang, Suping et al. (2005) Analysis of intimal proteoglycans in atherosclerosis-prone and atherosclerosis-resistant human arteries by mass spectrometry. Mol Cell Proteomics 4:1350-7
Kattapuram, Taj; Yang, Suping; Maki, Jenny L et al. (2005) Protein kinase CK1alpha regulates mRNA binding by heterogeneous nuclear ribonucleoprotein C in response to physiologic levels of hydrogen peroxide. J Biol Chem 280:15340-7
Stone, James R (2004) An assessment of proposed mechanisms for sensing hydrogen peroxide in mammalian systems. Arch Biochem Biophys 422:119-24
Stone, James R (2004) Intimal hyperplasia in the distal ulnar artery; Influence of gender and implications for the hypothenar hammer syndrome. Cardiovasc Pathol 13:20-5